Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling

Europace

Volumn 7, Issue 5, 2005, Pages 500-507

  Žohar, Petra ^a   Kovacic M ^b   Brezocnik, M ^b   Podbregar, Matej ^a  

^a General Hospital Celje   (Slovenia)

^b UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Atrial fibrillation; Electrical cardioversion; Prediction

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVERSION; CHI SQUARE TEST; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENTROPY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RR INTERVAL; SINUS RHYTHM; STUDENT T TEST;

AGED; ATRIAL FIBRILLATION; BAYES THEOREM; CHI-SQUARE DISTRIBUTION; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MODELS, GENETIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23644449884     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1016/j.eupc.2005.04.007     Document Type: Article

References (35)

1. E.J. Benjamin D. Levy S.M. Vaziri R.B. D'Agostino A.J. Belanger P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham heart study JAMA 271 1994 840-844
2. G. Gronefeld S.H. Hohnloser Towards a consensus in rate versus rhythm control for management of atrial fibrillation: Insights from the PIAF trial Card Electrophysiol Rev 7 2003 113-117
3. G.C. Gronefeld J. Lilienthal K.H. Kuck S.H. Hohnloser Pharmacological intervention in atrial fibrillation (PIAF) study investigators. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study Eur Heart J 24 2003 1430-1436
4. E.J. Benjamin P.A. Wolf R.B. D'Agostino H. Silbershatz W.B. Kannel D. Levy Impact of atrial fibrillation on the risk of death: The Framingham heart study Circulation 98 1998 946-952
5. V. Fuster L.E. Rydén R.W. Asinger et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): North American Society of Pacing and Electrophysiology. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology Circulation 104 2001 2118-2150
6. P. Ricard S. Lévy J. Trigano et al. Prospective assessment of the minimum energy needed for external electrical cardioversion of atrial fibrillation Am J Cardiol 79 1997 815-816
7. R.G. Tieleman I.C. Van Gelder H.J. Crijns et al. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical re-modelling of the atria? J Am Coll Cardiol 31 1998 167-173
8. I.C. Van Gelder A.E. Tuinenburg B.S. Schoonderwoerd R.G. Tieleman H.J. Crijns Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation Am J Cardiol 84 1999 147R-151R
9. R. Ebrahimi S.A. Rubin Electrical cardioversion resulting in death from synchronization failure Am J Cardiol 74 1994 100-102
10. C.J. Bjerkelund O.M. Orning The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol 25 1969 208-216
11. D.W. Gale T.E. Grissom J.V. Mirenda Titration of intravenous anesthetics for cardioversion: A comparison of propofol, methohexital, and midazolam Crit Care Med 21 1993 1509-1513
12. G. Groenefeld J.R. Ehrlich S.H. Hohnloser Comparison of outpatient vs inpatient direct current cardioversion of atrial fibrillation: Safety, efficacy and cost savings Eur Heart J 5 Suppl. H 2003 19-24
13. P. Dobnik-Dubovski M. Bezocnik Using genetic programming to predict the macroporosity of woven cotton fabrics Text Res J 73 2002 187-194
14. M. Bezocnik J. Balic A genetic-based approach to simulation of self-organizing assembly Robot Comput Integrat Manufact 17 2001 113-120
15. S.M. Pincus Approximate entropy as a measure of system complexity Proc Natl Acad Sci U S A 88 1991 2297-2301
16. J.R. Koza Genetic programming II 1994 The MIT Press Massachusetts
17. W. Banzhaf P. Nordin E.R. Keller F.D. Francone Genetic programming: An introduction 1998 Morgan Kaufmann San Francisco, CA
18. E.J. Gallagher Clinical utility of likelihood ratios Ann Emerg Med 31 1998 391-397
19. A. Laupacis N. Sekar I.G. Stiell Clinical prediction rules. A review and suggested modifications of methodological studies JAMA 277 1997 488-494
20. D. Roy M. Talajic P. Dorian et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian trial of atrial fibrillation investigators N Engl J Med 342 2000 913-920
21. S. Lévy P. Lauribe E. Dolla et al. A randomized comparision of external and internal cardioversion of chronic atrial fibrillation Circulation 86 1992 1415-1420
22. S. Mittal S. Ayati K.M. Stein et al. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks Circulation 101 2000 1282-1287
23. R.E. Kerber J.B. Martins M.G. Kienzle et al. Energy, current and success in defibrillation and cardioversion: Clinical studies using an automated impedance-based method of energy adjustment Circulation 77 1988 1038-1046
24. P. Bjerregaard A. El-Shafei D.L. Janosik et al. Double external direct-current shocks for refractory atrial fibrillation Am J Cardiol 83 1999 972-974
25. J.A. Joglar M.H. Hamdan K. Ramaswamy et al. Initial energy for elective external cardioversion of persistent atrial fibrillation Am J Cardiol 86 2000 348-350
26. M.M. Gallagher X.H. Guo J.D. Poloniecki et al. Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter J Am Coll Cardiol 38 2001 1498-1504
27. M. Marinsek G.L. Larkin P. Zohar et al. Efficacy and impact of monophasic versus biphasic countershocks for transthoracic cardioversion of persistent atrial fibrillation Am J Cardiol 92 2003 988-991
28. G.B. Lumer D. Roy M. Talajic et al. Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial Eur Heart J 23 2002 1050-1056
29. A. De Simone M. De Pasquale C. De Matteis et al. Verapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF study) Eur Heart J 24 2003 1425-1429
30. J. Galperin M.V. Elizari P.A. Chiale et al. Grupo de Estudio de Fibrilacion Auricular Con Amiodarona (GEFACA) Investigators. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance J Cardiovasc Pharmacol Ther 8 2003 179-186
31. A.V. Mattioli S. Bonatti L. Bonetti G. Mattioli Left atrial size after cardioversion for atrial fibrillation: Effect of external direct current shock J Am Soc Echocardiogr 16 2003 271-276
32. J.A. Ortiz De Murua M. del Carmen Avila C. Ochoa L. de La Fuente J.C. Moreno De Vega F. del Campo et al. Independent predictive factors of acute and first year success after electrical cardioversion in patients with chronic atrial fibrillation Rev Esp Cardiol 54 2001 958-964
33. P. Coumel Paroxysmal atrial fibrillation: A disorder of autonomic tone? Eur Heart J 15 1994 9-16
34. J.P. Saul Y. Arai R.D. Berger L.S. Lilly W.S. Colucci R.J. Cohen Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis Am J Cardiol 61 1988 1292-1299
35. S. Vikman T.H. Makikallio S. Yli-Mayry M. Nurmi K.E. Airaksinen H.V. Huikuri Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion Ann Med 35 2003 36-42